Skip to main navigation

Home
About Us
FIND-IO™ Technology
Pipeline
Product Development
Partnering
Investors
Contact

Events and Presentations

Events and Presentations

Past Events

BofA Securities 2022 Healthcare Conference

May 10, 2022 at 10:40 AM PDT

Listen to webcast

Supporting Materials

View Presentation 2.2 MB

21st Annual Needham Virtual Healthcare Conference

Apr 12, 2022 at 3:00 PM EDT

Listen to webcast

Supporting Materials

View Presentation 9.6 MB

11th Annual SVB Leerink Global Healthcare Conference

Feb 16, 2022 at 10:40 AM EST

Listen to webcast

Supporting Materials

View Presentation 4.4 MB

Pagination

Current page 1
Page 2
Next page
Last page

Presentations

Corporate Presentation - April 2022

ASH 2021 – Siglec-15 is a Novel Immunomodulatory Protein and Therapeutic Target in Acute Lymphoblastic Leukemia

ASH 2021 – A Novel LAIR-1 Antibody Target Acute Myeloid Leukemia (AML) Stem Cells

NextCure Virtual Oncology Pipeline Update Presentation

SITC 2021 Oral Presentation: Clinical benefit through Siglec-15 targeting with NC318 antibody in subjects with Siglec-15 positive advanced solid tumors

SITC 2021 Poster - Blockade of the inhibitory collagen receptor LAIR-1, PD-L1, and TGF-β promotes anti-tumor activity through T cell activation and myeloid cell polarization

SITC 2021 Poster - NC410, a fusion protein of LAIR-2 fused to human IgG1 Fc is safe and tolerable with evidence of immune modulation in subjects with advanced solid tumors

19th Annual Morgan Stanley Global Healthcare Conference Presentation

H. C. Wainwright 23rd Annual Global Investment Conference Presentation

JMP Securities Life Sciences Conference Presentation

NC410 ASCO 2021 Poster

BofA Securities 2021 Virtual Health Care Conference Presentation

Truist Securities Life Sciences Summit Presentation

Needham Healthcare Conference Presentation

NC762 AACR 2021 Poster

NextCure Virtual R&D Update Presentation

NC410 (Horn) SITC 2020 Poster

NC410 (Tian) SITC 2020 Poster

NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting

NextCure Hosts and Webcast Event at the 34th Annual Meeting of SITC

NextCure Presents Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of SITC

NextCure Presents Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (PDF)

Tools

9000 Virginia Manor Road | Suite 200 | Beltsville, MD 20705 | USA | (240) 399-4900